Seattle-area health data startup Truveta announced a collaboration Tuesday with Boston Scientific, a leading medical device company. The partnership will enable Boston Scientific researchers to access Truveta’s de-identified data from more than 65 million U.S. patients, with the aim of gathering insights into devices and disease states. To show the value of its approach, Truveta also released a preliminary analysis of peripheral artery disease linking various treatments and devices with outcomes. Truveta also recently released an overview of its findings on COVID-19, and added four new health systems to its network, bringing the total to 24. Terms of the deal with Boston Scientific were not disclosed.
Health data company Truveta inks partnership with Boston Scientific, releases COVID-19 data